Lurosetron

Last updated
Lurosetron
Lurosetron.png
Clinical data
ATC code
  • none
Identifiers
  • 6-fluoro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
Formula C17H17FN4O
Molar mass 312.348 g·mol−1
3D model (JSmol)
  • CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=C(N3C)C(=CC=C4)F
  • InChI=1S/C17H17FN4O/c1-10-13(20-9-19-10)8-22-7-6-14-15(17(22)23)11-4-3-5-12(18)16(11)21(14)2/h3-5,9H,6-8H2,1-2H3,(H,19,20) X mark.svgN
  • Key:NUMKWGDDRWJQMY-UHFFFAOYSA-N X mark.svgN
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Lurosetron (INN) is a serotonin 5-HT3 receptor antagonist. [1]

Synthesis

Lurosetron synthesis Lurosetron synthesis.svg
Lurosetron synthesis

References

  1. ↑ Prakash SP, Cable KM, Correa ID, Fellows L, Montgomery S, Newman JJ, Waterhouse L, Wells GN, Sutherland DR (1995). "Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists". Journal of Labelled Compounds and Radiopharmaceuticals. 36 (10): 993–1007. doi:10.1002/jlcr.2580361011.
  2. ↑ EP 0353983,Coates, Ian Harold; Oxford, Alexander William& North, Peter Charleset al.,published 1990-02-07, assigned to Glaxo Group Ltd.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.